SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Genzyme Corp – ‘10-K’ for 12/31/08 – EX-21

On:  Monday, 3/2/09, at 4:48pm ET   ·   For:  12/31/08   ·   Accession #:  1047469-9-2134   ·   File #:  0-14680

Previous ‘10-K’:  ‘10-K’ on 2/29/08 for 12/31/07   ·   Next:  ‘10-K’ on 3/1/10 for 12/31/09   ·   Latest:  ‘10-K/A’ on 3/24/11 for 12/31/10

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/02/09  Genzyme Corp                      10-K       12/31/08   12:2.2M                                   Merrill Corp/New/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    282K 
 2: EX-10.14.1  Material Contract                                   HTML     44K 
 3: EX-10.14.2  Material Contract                                   HTML     45K 
 4: EX-10.16    Material Contract                                   HTML     44K 
 5: EX-13       Annual or Quarterly Report to Security Holders      HTML   1.16M 
 6: EX-21       Subsidiaries of the Registrant                      HTML     15K 
 7: EX-23       Consent of Experts or Counsel                       HTML     16K 
 8: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     14K 
 9: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     14K 
10: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 
11: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 
12: EX-99       Miscellaneous Exhibit                               HTML    122K 


EX-21   —   Subsidiaries of the Registrant
Exhibit Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Exhibit 21
"Subsidiaries of the Registrant
"QuickLinks

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 21


SUBSIDIARIES OF THE REGISTRANT

Name
  Direct Parent(s)   Ownership   Jurisdiction of
Incorporation

Genzyme Europe B.V. 

  Imtix SangStat (Switzerland) GmbH     100 % The Netherlands

Genzyme Flanders BVBA

  Genzyme International Holdings Limited
Genzyme Global S.à.r.l.
    99.9
0.1
%
%
Belgium

Genzyme International Holdings Limited

  Genzyme Global S.à.r.l.     100 % Republic of Ireland

Genzyme Ireland Limited

  Genzyme International Holdings Limited     100 % Republic of Ireland

Genzyme Limited

  Genzyme Global S.à.r.l     100 % United Kingdom

Genzyme Securities Corporation

  Genzyme Therapeutic Products Limited Partnership     100 % Massachusetts, United States

Genzyme Polyclonals S.A.S. 

  SangStat Medical, LLC
SangStat Atlantique S.A.S.
    1
99
%
%
France

Genzyme Therapeutic Products Limited
Partnership

   
Genzyme Therapeutic Products Corporation
Genzyme Corporation
      
1
99

%
%
  
Massachusetts, United States

Genzyme Therapeutic Products Corporation

  Genzyme Corporation     100 % Massachusetts, United States

Imtix SangStat (Switzerland) GmbH

  Genzyme Global S.à.r.l.     100 % Switzerland

SangStat Atlantique S.A.S. 

  SangStat Medical, LLC     100 % France

Genzyme Global S.à.r.l. 

  Genzyme Luxembourg S.à.r.l.     100 % Luxembourg

Genzyme Luxembourg S.à.r.l. 

  Genzyme Corporation     100 % Luxembourg



QuickLinks

SUBSIDIARIES OF THE REGISTRANT
Top
Filing Submission 0001047469-09-002134   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 7:32:57.1am ET